The broken lines of the drawings illustrate portions of the handheld multi-modal imaging device that form no part of the claimed design.
The broken lines of the drawings illustrate portions of the handheld multi-modal imaging device that form no part of the claimed design.
Number | Name | Date | Kind |
---|---|---|---|
D414867 | Moriwaki | Oct 1999 | S |
5971918 | Zanger | Oct 1999 | A |
6571119 | Hayashi | May 2003 | B2 |
6601997 | Ngo | Aug 2003 | B2 |
D480478 | Leonard et al. | Oct 2003 | S |
6678398 | Wolters et al. | Jan 2004 | B2 |
6889075 | Marchitto et al. | May 2005 | B2 |
D515214 | Jackson, III et al. | Feb 2006 | S |
D569378 | Wanamaker | May 2008 | S |
D585554 | Suzuki | Jan 2009 | S |
D605759 | Cuevas | Dec 2009 | S |
D610178 | Adolfsson et al. | Feb 2010 | S |
7846091 | Fulghum | Dec 2010 | B2 |
D636424 | Lin | Apr 2011 | S |
D658298 | Prpa | Apr 2012 | S |
D677793 | Prpa | Mar 2013 | S |
8620410 | Frangioni | Dec 2013 | B2 |
D698937 | Laverack | Feb 2014 | S |
D701606 | Ohmukai | Mar 2014 | S |
D703331 | Kitayama | Apr 2014 | S |
D703333 | Saeki | Apr 2014 | S |
D724234 | Hagege | Mar 2015 | S |
9042967 | Dacosta et al. | May 2015 | B2 |
D733595 | Hoshino | Jul 2015 | S |
D747391 | Sakai | Jan 2016 | S |
D748808 | Matsumura et al. | Feb 2016 | S |
D750260 | Sauer | Feb 2016 | S |
D753308 | Marinkovich et al. | Apr 2016 | S |
D755062 | Yarden | May 2016 | S |
9326666 | Frangioni | May 2016 | B2 |
9340490 | Okura et al. | May 2016 | B2 |
9451882 | Nie et al. | Sep 2016 | B2 |
D787684 | Vezina | May 2017 | S |
9743836 | Tsubouchi et al. | Aug 2017 | B2 |
D802777 | Burachynsky et al. | Nov 2017 | S |
D810293 | Peel | Feb 2018 | S |
D822747 | Van Deusen et al. | Jul 2018 | S |
D822748 | Van Deusen et al. | Jul 2018 | S |
D827014 | Sakai | Aug 2018 | S |
D835271 | Myers et al. | Dec 2018 | S |
D849105 | Hogstedt et al. | May 2019 | S |
D859498 | Lin | Sep 2019 | S |
D861176 | Yoon et al. | Sep 2019 | S |
D861764 | Zhao | Oct 2019 | S |
D862697 | Kenworthy et al. | Oct 2019 | S |
10438356 | Dacosta | Oct 2019 | B2 |
D865836 | Puusaari | Nov 2019 | S |
D865845 | Sakai | Nov 2019 | S |
D866764 | Pukall | Nov 2019 | S |
D868867 | Jean et al. | Dec 2019 | S |
D873890 | Fidler | Jan 2020 | S |
D884175 | Aubailly | May 2020 | S |
D907097 | Suurmeijer et al. | Jan 2021 | S |
D908161 | Dacosta et al. | Jan 2021 | S |
D908881 | Dacosta et al. | Jan 2021 | S |
D921736 | Yin | Jan 2021 | S |
D910105 | Lin | Feb 2021 | S |
D910182 | Dacosta et al. | Feb 2021 | S |
D913354 | Marzette, Jr. et al. | Mar 2021 | S |
D914220 | Nelson et al. | Mar 2021 | S |
D916294 | Murray et al. | Apr 2021 | S |
D919690 | Suurmeijer et al. | May 2021 | S |
D921899 | Suarez et al. | Jun 2021 | S |
D922469 | Sjogren et al. | Jun 2021 | S |
D924306 | Melnicoff | Jul 2021 | S |
D930845 | Schmidt | Sep 2021 | S |
D958991 | Dacosta | Jul 2022 | S |
20030191368 | Wang et al. | Oct 2003 | A1 |
20050288594 | Lewkowicz et al. | Dec 2005 | A1 |
20060004292 | Beylin | Jan 2006 | A1 |
20100145146 | Melder | Jun 2010 | A1 |
20100145419 | Fraval | Jun 2010 | A1 |
20100292580 | Gilhuly et al. | Nov 2010 | A1 |
20110275900 | Gilhuly et al. | Nov 2011 | A1 |
20120165627 | Yamamoto | Jun 2012 | A1 |
20130338479 | Pogue et al. | Dec 2013 | A1 |
20140180116 | Lindekugel et al. | Jun 2014 | A1 |
20140276102 | Lee et al. | Sep 2014 | A1 |
20150030542 | Singhal | Jan 2015 | A1 |
20150038837 | Inoue et al. | Feb 2015 | A1 |
20150150460 | Krishnaswamy et al. | Jun 2015 | A1 |
20150182196 | Ninomiya et al. | Jul 2015 | A1 |
20160045114 | Dacosta et al. | Feb 2016 | A1 |
20160206202 | Frangioni | Jul 2016 | A1 |
20160287211 | DaCosta et al. | Oct 2016 | A1 |
20170085855 | Roberts et al. | Mar 2017 | A1 |
20170235118 | Kuster et al. | Aug 2017 | A1 |
20170290515 | Butte et al. | Oct 2017 | A1 |
20180218508 | Lee et al. | Aug 2018 | A1 |
20180234603 | Moore et al. | Aug 2018 | A1 |
20180242848 | Dacosta et al. | Aug 2018 | A1 |
20180252909 | Regensburger et al. | Sep 2018 | A1 |
20180276814 | Frangioni | Sep 2018 | A1 |
20180279864 | Frangioni | Oct 2018 | A1 |
20180325377 | Dacosta et al. | Nov 2018 | A1 |
20190079011 | Frangioni | Mar 2019 | A1 |
20210378584 | Takahashi | Dec 2021 | A1 |
Number | Date | Country |
---|---|---|
208795 | Mar 2022 | CA |
106983495 | Jul 2017 | CN |
304554755 | Mar 2018 | CN |
307182522 | Mar 2022 | CN |
307545922 | Sep 2022 | CN |
2502551 | Sep 2012 | EP |
3372143 | Sep 2018 | EP |
2011521237 | Jul 2011 | JP |
300827516.0000 | Nov 2015 | KR |
2010080611 | Jul 2010 | WO |
2013184830 | Dec 2013 | WO |
2016011534 | Jan 2016 | WO |
2016063949 | Apr 2016 | WO |
2017079844 | May 2017 | WO |
2017082242 | May 2017 | WO |
2017096137 | Jun 2017 | WO |
2018145193 | Aug 2018 | WO |
2019148268 | Aug 2019 | WO |
2019213737 | Nov 2019 | WO |
2020148724 | Jul 2020 | WO |
2020148725 | Jul 2020 | WO |
2020148726 | Jul 2020 | WO |
Entry |
---|
BayCare, Lumicell, Inc. Selects BayCare for Pivotal Breast Cancer Trial, Published on: Oct. 9, 2020, Baycare.org, Retrieved from Internet: https://baycare.org/newsroom/2020/october/lumicell-inc-selects-baycare-for-pivotal-breast-cancer-clinical-trial (Year: 2020). |
U.S. Appl. No. 29/842,182, filed Jun. 10, 2022. |
Office Action dated Jun. 21, 2022 in Brazilian Patent Application No. BR 302022000890-7. |
First Examination report dated Jun. 30, 2022 in Indian Patent Application No. 202017037681. |
Supplementary Partial European Search report dated Sep. 20, 2022 in related EP Application No. 20740856.8, 12 pages. |
Supplementary European Search report dated Sep. 20, 2022 in related EP Application No. 20741034.1, 27 pages. |
Supplementary European Search report dated Sep. 26, 2022 in related EP Application No. 20741678.5, 9 pages. |
Office Action dated Sep. 16, 2022 in related CA Application No. 3,127,036. |
Notice of Allowance dated Sep. 27, 2022 in related JP Application No. 2022-003401. |
Office Action dated Oct. 6, 2022 in related CA Application No. 3,127,048. |
Office Action dated Sep. 27, 2022 in related JP Application No. 2022-019073. |
European Search report dated Jan. 5, 2023 in related EP Application No. 20740856. 8. |
First Examination report dated Feb. 3, 2023 in related IN App No. 202117030136. |
U.S. Appl. No. 62/793,842, dated Jan. 17, 2019. |
U.S. Appl. No. 62/793,846, dated Jan. 17, 2019. |
U.S. Appl. No. 62/857,183, dated Jun. 4, 2019. |
Design U.S. Appl. No. 29/676,901, dated Jan. 15, 2019. |
Design U.S. Appl. No. 29/677,152, dated Jan. 17, 2019. |
International Search Report and Written Opinion from International Patent Application No. PCT/CA2019/000015, dated Jun. 4, 2019. |
“Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy”, 2017, Gao et al. https://www.researchgate.net/publication/315469453 Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy. |
“Current concepts and future perspectives on surgical optical imaging in cancer”,2010, Ntziachristos et al , https://vww.sniedigitallibrary.orMoumals/Jounial-of-Biomedical-Onticstvolume-15issue-61066024/Current-concepts-and-future-perspectives-on-surgical-optical-imaging-in/10.1117/1.3523364.full7SSO=I. |
Notice of Allowance in Design U.S. Appl. No. 29/677,154, dated Apr. 1, 2020. |
Notice of Allowance in Design U.S. Appl. No. 29/677,152, dated Apr. 1, 2020. |
Ex Parte Quayle Action in Design U.S. Appl. No. 29/676,901, dated Mar. 5, 2020. |
Notice of Allowance in Design U.S. Appl. No. 29/676,901, dated Jun. 4, 2020. |
International Search Report and Written Opinion from International Patent Application No. PCT/IB2020/050384 dated Apr. 22, 2020. |
Notice of Allowance in Design U.S. Appl. No. 29/762,417, dated Jan. 13, 2022, 13 pages. |
Notice of Allowance in Design U.S. Appl. No. 29/767,502 dated Mar. 11, 2022, 5 pages. |
Notice of Allowance in U.S. Appl. No. 29/767,874 dated Mar. 21, 2022. |
International Search Report and Written Opinion from International Patent Application No. PCT/IB2020/050385 dated Apr. 8, 2020. |
Notice of Allowance in Design U.S. Appl. No. 29/677,152, dated Sep. 22, 2020. |
Notice of Allowance in Design U.S. Appl. No. 29/676,901, dated Sep. 18, 2020. |
Ex Parte Quayle Action in Design U.S. Appl. No. 29/677,152, dated Dec. 20, 2019. |
Design U.S. Appl. No. 29/762,417, dated Dec. 16, 2020. |
Design U.S. Appl. No. 29/767,502, dated Jan. 22, 2021. |
U.S. Appl. No. 17/423,447, dated Jul. 15, 2021. |
U.S. Appl. No. 17/423,576, dated Jul. 16, 2021. |
U.S. Appl. No. 17/423,609, dated Jul. 16, 2021. |
Office Action dated Aug. 17, 2021 for U.S. Appl. No. 29/762,417, 9 pages. |
Design U.S. Appl. No. 29/804,808, dated Aug. 23, 2021. |
European Search Report for EP Application No. EP19746801 dated Sep. 13, 2021, 2 pages. |
“Nagaya et al” Fluorescence-Guided Surgery, Frontiers in Oncology, vol. 7, Dec. 22, 2017, 16 pp. |
Office Action dated Apr. 4, 2023 received in Japanese Patent Application No. 2020-541946. |
Written Opinion dated Apr. 21, 2023 in Singapore Patent Application No. 11202107275Q. |
Number | Date | Country | |
---|---|---|---|
Parent | 29767874 | Jan 2021 | US |
Child | 29842512 | US | |
Parent | 29677154 | Jan 2019 | US |
Child | 29767874 | US |